{"slug":"api-magentlab-com-api-calc-hfa-icos-vegf-1c6587","title":"Lyon 2020 HFA-ICOS baseline CV risk before VEGF inhibitors or VEGF TKIs","host":"api.magentlab.com","method":"POST","resource":"https://api.magentlab.com/api/calc/hfa_icos_vegf","category":"other","description":"Lyon 2020 HFA-ICOS baseline CV risk before VEGF inhibitors or VEGF TKIs. Very high if heart failure/cardiomyopathy or arterial vascular disease. High if venous thrombosis, LVEF <50%, QTc >=480 ms, age >=75, hypertension, prior anthracycline, or >=5 medium points. Medium if 2-4 medium points. Guide <","price_listed":0.005,"price_asked":0.007,"state":"overcharges","state_label":"Asked 1.4x its listed price for its own example","checks_7d":1,"answered_7d":1,"latency_ms_median":374,"reported_calls_30d":0,"reported_payers_30d":0,"networks":["eip155:8453"],"badge":"unverified","paid_checks_7d":0,"paid_ok_7d":0,"example_input":{"body":{"items":[{"age_years":50,"arrhythmia":false,"arterial_vascular_disease":false,"ckd":false,"current_or_significant_smoker":false,"diabetes":false,"elevated_bnp":false,"elevated_troponin":false,"heart_failure_or_cardiomyopathy":false,"hyperlipidemia":false,"hypertension":false,"lvef_percent":60,"obesity":false,"prior_anthracycline":false,"prior_left_chest_or_mediastinal_rt":false,"proteinuria":false,"qtc_ms":400,"sex":"female","venous_thrombosis":false},{"age_years":50,"arrhythmia":false,"arterial_vascular_disease":false,"ckd":false,"current_or_significant_smoker":false,"diabetes":false,"elevated_bnp":false,"elevated_troponin":false,"heart_failure_or_cardiomyopathy":false,"hyperlipidemia":false,"hypertension":false,"lvef_percent":60,"obesity":false,"prior_anthracycline":false,"prior_left_chest_or_mediastinal_rt":false,"proteinuria":false,"qtc_ms":400,"sex":"female","venous_thrombosis":false}]},"method":"POST","type":"http"},"output_schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"additionalProperties":false,"properties":{"items":{"items":{"properties":{"age_years":{"description":"Integer age in years (18-100) as assigned by the caller. Lyon 2020 VEGF-inhibitor table: >=75 High; 65-74 Medium 1; <65 no age points. Bands are exclusive. magent does not read an identity document.","type":"integer"},"arrhythmia":{"description":"Arrhythmia (atrial fibrillation, atrial flutter, ventricular tachycardia, or ventricular fibrillation) as assigned by the caller (Lyon 2020 VEGF-inhibitor table, Medium 2). true or false.","type":"boolean"},"arterial_vascular_disease":{"description":"Arterial vascular disease: IHD, PCI, CABG, stable angina, TIA, stroke, or PVD as one caller bool (Lyon 2020 VEGF-inhibitor table, very high). true or false. magent does not diagnose vascular disease.","type":"boolean"},"ckd":{"description":"Chronic kidney disease (eGFR <60 mL/min/1.73 m2) as assigned by the caller (Lyon 2020 VEGF-inhibitor table, Medium 1). true or false. magent does not compute eGFR.","type":"boolean"},"current_or_significant_smoker":{"description":"Current smoker or significant smoking history as assigned by the caller (Lyon 2020 VEGF-inhibitor table, Medium 1). true or false.","type":"boolean"},"diabetes":{"description":"Diabetes mellitus (glycated haemoglobin >7.0% or >53 mmol/mol, or on treatment) as assigned by the caller (Lyon 2020 VEGF-inhibitor table, Medium 1). true or false.","type":"boolean"},"elevated_bnp":{"description":"Elevated baseline BNP or NT-proBNP above the local laboratory upper limit of normal as assigned by the caller (Lyon 2020 VEGF-inhibitor table, Medium 1). true or false. magent does not assay BNP.","type":"boolean"},"elevated_troponin":{"description":"Elevated baseline troponin above the local laboratory upper limit of normal as assigned by the caller (Lyon 2020 VEGF-inhibitor table, Medium 1). true or false. magent does not assay troponin.","type":"boolean"},"heart_failure_or_cardiomyopathy":{"description":"Heart failure or cardiomyopathy (Lyon 2020 VEGF-inhibitor table, very high). Caller-assigned. true or false.","type":"boolean"},"hyperlipidemia":{"description":"Hyperlipidemia (non-HDL cholesterol >3.8 mmol/L or >145 mg/dL) as assigned by the caller (Lyon 2020 VEGF-inhibitor table, Medium 1). true or false. magent does not convert lipid units.","type":"boolean"},"hypertension":{"description":"Hypertension (SBP >140 mmHg or DBP >90 mmHg, or on treatment) as assigned by the caller (Lyon 2020 VEGF-inhibitor table, High). true or false. magent does not read a blood-pressure cuff.","type":"boolean"},"lvef_percent":{"description":"Baseline left-ventricular ejection fraction, integer percent 10-80, as assigned by the caller. <50 High; 50-54 Medium 2; >=55 no LVEF points. magent does not read an echocardiogram.","type":"integer"},"obesity":{"description":"Obesity (BMI >30 kg/m2) as assigned by the caller (Lyon 2020 VEGF-inhibitor table, Medium 1). true or false. magent does not compute BMI.","type":"boolean"},"prior_anthracycline":{"description":"Prior anthracycline exposure as assigned by the caller (Lyon 2020 VEGF-inhibitor table, High). true or false.","type":"boolean"},"prior_left_chest_or_mediastinal_rt":{"description":"Prior radiotherapy to the left chest or mediastinum as assigned by the caller (Lyon 2020 VEGF-inhibitor table, Medium 1). true or false.","type":"boolean"},"proteinuria":{"description":"Proteinuria as assigned by the caller (Lyon 2020 VEGF-inhibitor table, Medium 1). true or false.","type":"boolean"},"qtc_ms":{"description":"Baseline QTc in milliseconds, integer 300-700, as assigned by the caller. >=480 High; men 450-479 Medium 2; women 460-479 Medium 2. magent does not measure QTc.","type":"integer"},"sex":{"description":"male or female as assigned by the caller. Used only for the sex-specific borderline QTc Medium 2 band (men 450-479 ms; women 460-479 ms).","type":"string"},"venous_thrombosis":{"description":"Venous thrombosis (DVT or PE) as assigned by the caller (Lyon 2020 VEGF-inhibitor table, High). true or false.","type":"boolean"}},"required":["age_years","sex","lvef_percent","qtc_ms","heart_failure_or_cardiomyopathy","arterial_vascular_disease","venous_thrombosis","hypertension","prior_anthracycline","arrhythmia","elevated_troponin","elevated_bnp","diabetes","hyperlipidemia","ckd","proteinuria","prior_left_chest_or_mediastinal_rt","current_or_significant_smoker","obesity"],"type":"object"},"maxItems":25,"minItems":1,"type":"array"}},"required":["items"],"type":"object"},"headers":{"additionalProperties":{"type":"string"},"type":"object"},"method":{"const":"POST","type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method"],"type":"object"},"output":{"properties":{"example":{"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"},"history":[{"day":"2026-09-28","reachable":true,"status":402,"valid_402":true,"asked_usdc":0.007,"price_match":false,"latency_ms":374,"error":null}],"description_full":"Lyon 2020 HFA-ICOS baseline CV risk before VEGF inhibitors or VEGF TKIs. Very high if heart failure/cardiomyopathy or arterial vascular disease. High if venous thrombosis, LVEF <50%, QTc >=480 ms, age >=75, hypertension, prior anthracycline, or >=5 medium points. Medium if 2-4 medium points. Guide <2% / 2-9% / 10-19% / >=20%. Not a device or treatment order.","last_updated":"2026-09-28T13:45:21.937Z","schemes":["exact"]}